by John Conrad | Jul 24, 2024 | NewsBrief
In a significant development for Illinois’ healthcare technology sector, Endotronix has been acquired by Edwards Lifesciences, a global leader in patient-focused innovations for structural heart disease and critical care monitoring. This acquisition marks a...
by John Conrad | Jul 24, 2024 | NewsBrief
The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has forged a strategic partnership with Orange Grove Bio (OGB), an integrated biopharmaceutical company, in a move set to accelerate biotech innovation and commercialization. This...
by John Conrad | Jul 24, 2024 | NewsBrief
Valinor Pharma, LLC (“Valinor”) has announced its acquisition by Grünenthal in an all-stock deal valued at approximately $250 million in upfront cash consideration. This acquisition marks a significant milestone for Valinor, which has owned the global...
by John Conrad | Jul 19, 2024 | NewsBrief
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals has acquired the North American rights to CONTEPO™ (fosfomycin for injection) from Nabriva Therapeutics. The announcement, made on July 18, 2024, marks a significant...
by John Conrad | Jul 18, 2024 | NewsBrief
GE HealthCare announced today that it has entered into an agreement to acquire the clinical artificial intelligence (AI) software business of Intelligent Ultrasound Group PLC for approximately $51 million. The acquisition aims to integrate innovative AI-driven image...
by John Conrad | Jul 17, 2024 | NewsBrief
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available for research use only (RUO). IPS is the first offering of a larger immunotherapy-based...
